Enzyme-linked ImmunoSpot (ELISpot) assay to quantify peptide-specific IFN-γ production by splenocytes in a mouse tumor model after radiation therapy
Methods in Cell Biology · 2024
DOI: 10.1016/bs.mcb.2024.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Cell Biology, 2024. Verfasst von Benoît Lecoester und 6 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, EFS BFC, UMR 1098, RIGHT, Greffon-Hôte-Tumeur Interactions/Ingénierie Cellulaire et Génique, Université de Franche-Comté, Besançon, France. Hauptthemen laut MEDLINE: Interferon-gamma, CD8-Positive T-Lymphocytes, Spleen, Enzyme-Linked Immunospot Assay. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
To develop new effective therapeutic strategies for cancer patients, there is a need for extensive and precise insights into the mechanisms involved in the immune response to anti-cancer treatments. The enzyme-linked immunospot (ELISpot) assay is a rapid and reproducible technique that allows the detection of cytokine-producing antigen-specific T cells at the single cell level. This protocol describes an interferon gamma (IFN-γ) ELISpot method for measuring antigen-specific murine CD8+ T cells that produce IFN-γ, a marker of their activation and cytotoxicity. Splenocytes from tumor-bearing mice treated with radiation therapy were used as source of CD8+ T cells and were stimulated with a tumor-derived peptide. This method was facilitated by a ready-to-use assay kit and provides a tool to analyze the specificity, intensity, and kinetics of specific CD8+ T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, EFS BFC, UMR 1098, RIGHT, Greffon-Hôte-Tumeur Interactions/Ingénierie Cellulaire et Génique, Université de Franche-Comté, Besançon, France.
- INSERM, EFS BFC, UMR 1098, RIGHT, Greffon-Hôte-Tumeur Interactions/Ingénierie Cellulaire et Génique, Université de Franche-Comté, Besançon, France; Department of Medical Oncology, University Hospital of Besançon, Besanç…
- INSERM, EFS BFC, UMR 1098, RIGHT, Greffon-Hôte-Tumeur Interactions/Ingénierie Cellulaire et Génique, Université de Franche-Comté, Besançon, France; Department of Radiation Oncology, University Hospital of Besançon, Besa…
Zitieren
APA
Lecoester, B., Xie, Y., Marguier, A., Boulerot, L., Malfroy, M., Adotévi, O., & Boustani, J. (2024). Enzyme-linked ImmunoSpot (ELISpot) assay to quantify peptide-specific IFN-γ production by splenocytes in a mouse tumor model after radiation therapy. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2024.07.001
Vancouver
Lecoester B, Xie Y, Marguier A, Boulerot L, Malfroy M, Adotévi O, et al. Enzyme-linked ImmunoSpot (ELISpot) assay to quantify peptide-specific IFN-γ production by splenocytes in a mouse tumor model after radiation therapy. Methods in Cell Biology. 2024. doi:10.1016/bs.mcb.2024.07.001
BibTeX
@article{Lecoester2024,
author = {Lecoester, Benoît and Xie, Yaoyao and Marguier, Amélie and Boulerot, Laura and Malfroy, Marine and Adotévi, Olivier and Boustani, Jihane},
title = {Enzyme-linked ImmunoSpot (ELISpot) assay to quantify peptide-specific IFN-γ production by splenocytes in a mouse tumor model after radiation therapy},
journal = {Methods in Cell Biology},
year = {2024},
doi = {10.1016/bs.mcb.2024.07.001}
}
EUVIMED